Influenza Vaccination clinical trials

Explore recruiting influenza vaccination clinical trials.

Recruiting influenza vaccination studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Influenza Vaccination trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Antibody Glycosylation dynamics After Vaccination (AGAVE)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Effect of Influenza Vaccination on Global Systemic Inflammatory Markers in Patients With Stable Coronary Artery Disease - Randomized Delayed-Start Pilot Trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Impact of influenza vaccination on nasal resident memory immune responses and respiratory peripheral memory immune responses - MUCOVAC 2

France

Therapeutic use (Phase IV) EU CTIS Study details

B7471015 - A PHASE 4 STUDY USING A TEST-NEGATIVE DESIGN TO EVALUATE THE EFFECTIVENESS OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE AGAINST VACCINE-TYPE RADIOLOGICALLY-CONFIRMED COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS ≥65 YEARS OF AGE

Spain

Therapeutic use (Phase IV) EU CTIS Study details

INfluenza VaccInation To mitigate typE 1 Diabetes (INVITED trial)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of infLuenza vaccInation after Myocardial INfArction on cardiac inflammaTory responsE - a randomized, double-blind, placebo-controlled, trial (ELIMINATE trial)

Sweden, Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Influenza Vaccination trials by city

Influenza Vaccination in Toronto Influenza Vaccination in Vancouver Influenza Vaccination in Montreal Influenza Vaccination in Calgary Influenza Vaccination in Edmonton Influenza Vaccination in Ottawa Influenza Vaccination in Winnipeg Influenza Vaccination in Quebec City Influenza Vaccination in Hamilton Influenza Vaccination in Kitchener Influenza Vaccination in London Influenza Vaccination in Halifax Influenza Vaccination in New York Influenza Vaccination in Los Angeles Influenza Vaccination in Chicago Influenza Vaccination in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease